Clinical Trial Update: Serotonergic Pharmacotherapy for Agitation of Dementia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a serotonergic treatment for agitation in dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia
• Vascular Dementia

Snippet

Sponsor: Bruce Pollock | Conditions: Dementia, Alzheimer Disease | Phase 3 | Status: COMPLETED